Qianzhou Lv

10PUBLICATIONS
4CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Respiratory diseasesMolecular targetsPharmacogenomicsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 15, 2025
The Effect of PCSK9 Monoclonal Antibodies on Platelet Reactivity and Cardiovascular Events in Patients Receiving Primary Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis.

Yao Yao, Qining Qiu, Zi Wang

|Aug 29, 2024
Co-Administration of Amiodarone Increases Bleeding by Affecting Rivaroxaban Pharmacokinetics in Patients with Atrial Fibrillation.

Huamin Ding, Zi Wang, Jia Wang

|Jul 30, 2024
Clinical Effectiveness and Safety Comparison between Reduced Rivaroxaban Dose and Dual Antiplatelet Therapy for Nonvalvular Atrial Fibrillation Patients Following Percutaneous Left Atrial Appendage Closure: A Prospective Observational Study.

Xiaoye Li, Qinchun Jin, Yao Yao

|Mar 20, 2024
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure.

Yao Yao, Yanli Li, Qinchun Jin

|Aug 05, 2023
Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation.

Xiaoye Li, Zhichun Gu, Zi Wang

|Jan 13, 2023
The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study.

Yao Yao, Xiaoye Li, Zi Wang

Pageof 2

Frequent Collaborators

1 joint publications

Xiaochun Zhang

1 joint publications

Jia Wang

1 joint publications

Chi Zhang

1 joint publications

Zhichun Gu